What you need to know about Johnson & Johnson’s 2022 third-quarter earnings
Check out this infographic breakdown of the company’s third-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
This morning, Johnson & Johnson shared its third-quarter performance.
Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 144,000 employees across the globe working every day to help change the trajectory of health for humanity.
“The solid results delivered this quarter, including accelerated operational sales* growth in all three of our segments, reflect the strength of our business, versatility of our operations, and the unwavering commitment of Johnson & Johnson’s employees to patients and consumers around the world,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We invested in R&D at increased levels, advanced our pipeline and returned significant value to shareholders. Looking ahead, we will continue to execute against our long-term strategy, focused on improving health outcomes and access to care.”
For more details about the company’s 2022 third-quarter results, and to read a message from Chief Executive Officer Joaquin Duato, here’s an infographic that highlights key stats.
*Non-GAAP financial measure. Refer to the reconciliations in the full press release.
Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.